SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-366169
Filing Date
2021-12-23
Accepted
2021-12-23 16:05:55
Documents
12
Period of Report
2021-12-22
Items
Item 1.02: Termination of a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K d272318d8k.htm   iXBRL 8-K 24128
  Complete submission text file 0001193125-21-366169.txt   149805

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ymtx-20211222.xsd EX-101.SCH 2880
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ymtx-20211222_lab.xml EX-101.LAB 18888
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ymtx-20211222_pre.xml EX-101.PRE 11852
6 EXTRACTED XBRL INSTANCE DOCUMENT d272318d8k_htm.xml XML 3520
Mailing Address 40 GUEST STREET SUITE 4410 BOSTON MA 02135
Business Address 40 GUEST STREET SUITE 4410 BOSTON MA 02135 617-409-5300
YUMANITY THERAPEUTICS, INC. (Filer) CIK: 0001445283 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37695 | Film No.: 211517181
SIC: 2834 Pharmaceutical Preparations